发布求助
文献互助 智能选刊 最新文献

Journal of Thoracic Oncology最新文献

筛选
英文 中文
MA01.11 Unveiling Gene Expression and Immune Contexture in Stage II/III NSCLC Patients Receiving Neoadjuvant Pembrolizumab and Chemotherapy MA01.11 揭示接受彭博利珠单抗新辅助化疗的II/III期NSCLC患者的基因表达和免疫内涵
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.097
Y. Chen , Y. Su , R. Zhang , S. Wang , J. Zhang , X. Sun , G. Zhao , Q. Ou , J. You
{"title":"MA01.11 Unveiling Gene Expression and Immune Contexture in Stage II/III NSCLC Patients Receiving Neoadjuvant Pembrolizumab and Chemotherapy","authors":"Y. Chen , Y. Su , R. Zhang , S. Wang , J. Zhang , X. Sun , G. Zhao , Q. Ou , J. You","doi":"10.1016/j.jtho.2024.09.097","DOIUrl":"10.1016/j.jtho.2024.09.097","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S55-S56"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MA02.03 Circulating T Cell Receptor Repertoire Analysis Improves Cancer Early Detection MA02.03 循环 T 细胞受体汇集分析可提高癌症早期检测能力
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.100
Y. Li , M. Nahas , D. Stephens , K. Froburg , E. Hintz , D. Champagne , A. Lochab , M. Brown , J. Braun , M.A. Fortuño , M-d-M. Ocón , A. Pasquier , I.M. Luque , C.W. Seder , J.A. Borgia , L.M. Seijo , L.M. Montuenga , R. Yelensky
{"title":"MA02.03 Circulating T Cell Receptor Repertoire Analysis Improves Cancer Early Detection","authors":"Y. Li , M. Nahas , D. Stephens , K. Froburg , E. Hintz , D. Champagne , A. Lochab , M. Brown , J. Braun , M.A. Fortuño , M-d-M. Ocón , A. Pasquier , I.M. Luque , C.W. Seder , J.A. Borgia , L.M. Seijo , L.M. Montuenga , R. Yelensky","doi":"10.1016/j.jtho.2024.09.100","DOIUrl":"10.1016/j.jtho.2024.09.100","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S57"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC OA01.03 早期NSCLC围手术期Pembrolizumab的KEYNOTE-671研究中病理消退与EFS的关系
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.022
D.R. Jones , H. Wakelee , J.D. Spicer , M. Liberman , T. Kato , M. Tsuboi , S.-H. Lee , W. Wang , H. Chen , C. Dooms , M. Majem , E. Eigendorff , G.L. Martinengo , O. Bylicki , H.-C. Huang , S. Novello , E. Jensen , S.M. Keller , A. Samkari , N. Kalhor
{"title":"OA01.03 Association of Pathologic Regression with EFS in the KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC","authors":"D.R. Jones , H. Wakelee , J.D. Spicer , M. Liberman , T. Kato , M. Tsuboi , S.-H. Lee , W. Wang , H. Chen , C. Dooms , M. Majem , E. Eigendorff , G.L. Martinengo , O. Bylicki , H.-C. Huang , S. Novello , E. Jensen , S.M. Keller , A. Samkari , N. Kalhor","doi":"10.1016/j.jtho.2024.09.022","DOIUrl":"10.1016/j.jtho.2024.09.022","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S8"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142440973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA13.05 I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer OA13.05 i-sabr-select：基于放射组学的早期非小细胞肺癌个性化免疫疗法模型
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.071
M.B. Saad , E. Showkatian , Q. Al-Tashi , M. Aminu , X. Xinyan , M. Qayati Mohamed , M. Salehjahromi , S.J. Sujit , S.H. Lin , Z. Liao , S. Gandhi , D. Qian , D.A. Jaffray , C. Chung , N. Vokes , J. Zhang , J.V. Heymach , J. Wu , J.Y. Chang
{"title":"OA13.05 I-SABR-SELECT: A Radiomics-Based Model for Personalized Immunotherapy for Early-Stage Non-Small Cell Lung Cancer","authors":"M.B. Saad , E. Showkatian , Q. Al-Tashi , M. Aminu , X. Xinyan , M. Qayati Mohamed , M. Salehjahromi , S.J. Sujit , S.H. Lin , Z. Liao , S. Gandhi , D. Qian , D.A. Jaffray , C. Chung , N. Vokes , J. Zhang , J.V. Heymach , J. Wu , J.Y. Chang","doi":"10.1016/j.jtho.2024.09.071","DOIUrl":"10.1016/j.jtho.2024.09.071","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S40"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study OA10.04 塔拉他单抗联合 PD-L1 抑制剂作为 ES-SCLC 化疗免疫疗法后的一线维持治疗：DeLLphi-303 1b 期研究
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.058
S. Lau , M.-J. Ahn , M. Moskovitz , M. Pogorzelski , S. Haefliger , K.G. Paulson , A. Parkes , Y. Zhang , A. Hamidi , M. Wermke
{"title":"OA10.04 Tarlatamab with a PD-L1 Inhibitor as First-Line Maintenance after Chemo-immunotherapy for ES-SCLC: DeLLphi-303 Phase 1b Study","authors":"S. Lau , M.-J. Ahn , M. Moskovitz , M. Pogorzelski , S. Haefliger , K.G. Paulson , A. Parkes , Y. Zhang , A. Hamidi , M. Wermke","doi":"10.1016/j.jtho.2024.09.058","DOIUrl":"10.1016/j.jtho.2024.09.058","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S31-S32"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142441321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Familial Lung Cancers Caused by EGFR Germline Mutations: The Frequency Is Probably Underestimated but Specific Genotypic Features and Some Particular Disease Characteristics Should Help Their Screening 表皮生长因子受体基因突变导致的家族性肺癌：频率可能被低估，但特定基因型特征和某些特定疾病特征应有助于筛查。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.07.007
Jean Louis Pujol PhD, PD , Wilfried Ernst Erich Eberhardt MD
{"title":"Familial Lung Cancers Caused by EGFR Germline Mutations: The Frequency Is Probably Underestimated but Specific Genotypic Features and Some Particular Disease Characteristics Should Help Their Screening","authors":"Jean Louis Pujol PhD, PD , Wilfried Ernst Erich Eberhardt MD","doi":"10.1016/j.jtho.2024.07.007","DOIUrl":"10.1016/j.jtho.2024.07.007","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages 1364-1366"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meeting Announcements 会议公告
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/S1556-0864(24)00807-4
{"title":"Meeting Announcements","authors":"","doi":"10.1016/S1556-0864(24)00807-4","DOIUrl":"10.1016/S1556-0864(24)00807-4","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page A4"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142416068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA09.05 Subcutaneous vs Intravenous Amivantamab: Patient Satisfaction and Resource Utilization Results from the PALOMA-3 Study OA09.05 皮下注射与静脉注射阿米万他单抗：PALOMA-3研究的患者满意度和资源利用结果
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.055
M. Alexander , Y. Cheng , S.-H. Lee , A. Passaro , A.I. Spira , B.C. Cho , S.M. Lim , Y. Ohe , A. Nagrial , J.L. Tan , V. Wainsztein , E. Ramos , M. del Rosario Garcia Campelo , H. Akamatsu , D. Nguyen , A.B. Cortot , A. Zer , D. Erdem , R.E. Sanborn , T.-O. Emde , N.B. Leighl
{"title":"OA09.05 Subcutaneous vs Intravenous Amivantamab: Patient Satisfaction and Resource Utilization Results from the PALOMA-3 Study","authors":"M. Alexander , Y. Cheng , S.-H. Lee , A. Passaro , A.I. Spira , B.C. Cho , S.M. Lim , Y. Ohe , A. Nagrial , J.L. Tan , V. Wainsztein , E. Ramos , M. del Rosario Garcia Campelo , H. Akamatsu , D. Nguyen , A.B. Cortot , A. Zer , D. Erdem , R.E. Sanborn , T.-O. Emde , N.B. Leighl","doi":"10.1016/j.jtho.2024.09.055","DOIUrl":"10.1016/j.jtho.2024.09.055","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Page S29"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ficonalkib’s Promise and the Path Forward: A Comment on Advanced ALK-Positive NSCLC Treatment Ficonalkib 的承诺与前进之路：关于 ALK 阳性 NSCLC 晚期治疗的评论。
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.06.019
Meng-Wei Ge MS, Hong-Lin Chen MD
{"title":"Ficonalkib’s Promise and the Path Forward: A Comment on Advanced ALK-Positive NSCLC Treatment","authors":"Meng-Wei Ge MS, Hong-Lin Chen MD","doi":"10.1016/j.jtho.2024.06.019","DOIUrl":"10.1016/j.jtho.2024.06.019","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages e47-e48"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142381176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OA05.03 Ablation to Oligo-Residual Sites Plus ICIs Improved Survival of Patients with Advanced NSCLC: Preliminary Results of a Prospective Phase II Trial OA05.03 消融寡核苷酸残留部位加 ICIs 可提高晚期 NSCLC 患者的生存率：前瞻性 II 期试验的初步结果
IF 21 1区 医学
Journal of Thoracic Oncology Pub Date : 2024-10-01 DOI: 10.1016/j.jtho.2024.09.037
S. Yang, B. Chen, J. Yu, X. Liu, T. Jiang, F. Wu, A. Li, G. Gao, X. Chen, S. Ren
{"title":"OA05.03 Ablation to Oligo-Residual Sites Plus ICIs Improved Survival of Patients with Advanced NSCLC: Preliminary Results of a Prospective Phase II Trial","authors":"S. Yang, B. Chen, J. Yu, X. Liu, T. Jiang, F. Wu, A. Li, G. Gao, X. Chen, S. Ren","doi":"10.1016/j.jtho.2024.09.037","DOIUrl":"10.1016/j.jtho.2024.09.037","url":null,"abstract":"","PeriodicalId":17515,"journal":{"name":"Journal of Thoracic Oncology","volume":"19 10","pages":"Pages S17-S18"},"PeriodicalIF":21.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142442366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信